Warning: The NCBI web site requires JavaScript to function. more...
Immunotherapy: rAAV2 expressing interleukin-15 inhibits HeLa cell tumor growth in mice.
Yiang GT, Harn HJ, Yu YL, Hu SC, Hung YT, Hsieh CJ, Lin SZ, Wei CW.
J Biomed Sci. 2009 May 7;16:47.
Related citations
Immunotherapy of breast cancer by single delivery with rAAV2-mediated interleukin-15 expression.
Yu YL, Wei CW, Chen YL, Chen MH, Yiang GT.
Int J Oncol. 2010 Feb;36(2):365-70.
AAV2-mediated interleukin-12 in the treatment of malignant brain tumors through activation of NK cells.
Chiu TL, Lin SZ, Hsieh WH, Peng CW.
Int J Oncol. 2009 Dec;35(6):1361-7.
Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells.
Li L, Yang L, Scudiero DA, Miller SA, Yu ZX, Stukenberg PT, Shoemaker RH, Kotin RM.
Gene Ther. 2007 May;14(10):814-27. Epub 2007 Mar 1.
Estrogen plays a critical role in AAV2-mediated gene transfer in ovarian cancer.
Shi WF, Bartlett JS.
Acta Pharmacol Sin. 2008 Dec;29(12):1440-50.
[Preparation of rAAV2/hFIX and experimentally application to gene therapy for hemophilia B].
Peng JQ, Dong XY, Peng M, Chen L, Tan SP, Yuan H, Chen FP, Xue JL, Wu XB.
Zhonghua Xue Ye Xue Za Zhi. 2004 Sep;25(9):513-8. Chinese.
More than chemotaxis: a new anti-tumor DC vaccine modified by rAAV2-SLC.
Liang CM, Ye SL, Zhong CP, Zheng N, Bian W, Sun RX, Chen J, Li RL, Zhou S, Liu YK.
Mol Immunol. 2007 Jul;44(15):3797-804. Epub 2007 May 22.
Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery.
Towne C, Pertin M, Beggah AT, Aebischer P, Decosterd I.
Mol Pain. 2009 Sep 8;5:52.
Recombinant adeno-associated and adenoviral vectors for the transduction of pancreatic and colon carcinoma.
Teschendorf C, Warrington KH Jr, Shi W, Siemann DW, Muzyczka N.
Anticancer Res. 2006 Jan-Feb;26(1A):311-7.
Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin.
Cai KX, Tse LY, Leung C, Tam PK, Xu R, Sham MH.
Clin Cancer Res. 2008 Feb 1;14(3):939-49.
Efficient recovery of HLA class I expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: implications for cancer immunotherapy.
del Campo AB, Aptsiauri N, Méndez R, Zinchenko S, Vales A, Paschen A, Ward S, Ruiz-Cabello F, González-Aseguinolaza G, Garrido F.
Scand J Immunol. 2009 Aug;70(2):125-35.
Systemic cancer gene therapy using adeno-associated virus type 1 vector expressing MDA-7/IL24.
Tahara I, Miyake K, Hanawa H, Kurai T, Hirai Y, Ishizaki M, Uchida E, Tajiri T, Shimada T.
Mol Ther. 2007 Oct;15(10):1805-11. Epub 2007 Jun 5.
Chemotherapeutic agents enhance AAV2-mediated gene transfer into breast cancer cells promoting CD40 ligand-based immunotherapy.
Koppold B, Sauer G, Buening H, Hallek M, Kreienberg R, Deissler H, Kurzeder C.
J Cancer Res Clin Oncol. 2006 Dec;132(12):787-94. Epub 2006 Jun 23.
[Development of rAAV2-GAD-Ig for IDDM gene therapy].
Wang RX, Wang JA, Song L, Han GC, Shen BF, Wu XB, Li Y.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005 Jan;21(1):24-8. Chinese.
Effect of recombinant adenovirus vector mediated human interleukin-24 gene transfection on pancreatic carcinoma growth.
Pan XT, Zhu QY, Li DC, Yang JC, Zhang ZX, Zhu XG, Zhao H.
Chin Med J (Engl). 2008 Oct 20;121(20):2031-6.
Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adeno-associated virus vector does not prevent acute rejection.
Laurence JM, Wang C, Zheng M, Cunningham S, Earl J, Tay SS, Allen RD, McCaughan GW, Alexander IE, Bishop GA, Sharland AF.
Liver Transpl. 2009 Feb;15(2):233-41.
[Construction and expression of recombinant adeno-associated virus vector containing HSV1-TK gene].
Ding ZX, Tan Q, Liu SZ, Liu D, Li ZQ, Peng JQ.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008 Mar;33(3):210-5. Chinese.
Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapy.
Tosch C, Geist M, Ledoux C, Ziller-Remi C, Paul S, Erbs P, Corvaia N, Von Hoegen P, Balloul JM, Haegel H.
Cancer Gene Ther. 2009 Apr;16(4):310-9. Epub 2008 Oct 24.
[Construction of rAAV2-GPIIb/IIIa vector and test of its expression and function in vitro].
Wang K, Peng JQ, Chen FP, Wu XB.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Apr;14(2):369-74. Chinese.
Application of doxorubicin-induced rAAV2-p53 gene delivery in combined chemotherapy and gene therapy for hepatocellular carcinoma.
Chen CA, Lo CK, Lin BL, Sibley E, Tang SC.
Cancer Biol Ther. 2008 Feb;7(2):303-9. Epub 2007 Nov 21.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on